Jupiter Neurosciences

JUNSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$288.253 M

$5.10 -9.46%

Close of 7 Aug 2026

Revenue

$21.8K

#3642 by revenue

Earnings

-$8.64M

Loss-making

Shares outstanding

36,281,252

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#238Bicycle TherapeuticsBCYC$291.9M
#239ImmuneeringIMRX$291.8M
#240Jupiter NeurosciencesJUNS$288.3M
#241Natures Sunshine ProductsNATR$288.0M
#242CellectisCLLS$285.0M

Where these numbers come from

Share counts and financials for Jupiter Neurosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.